Understanding Interchangeable Biosimilars at the Federal and State Levels
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
Source: ajmc.com
Interchangeable Biosimilars News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Interchangeable Biosimilars. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Interchangeable Biosimilars Today - Breaking & Trending Today
Cost and Time Benefits of Interchangeable Biosimilars
Kimberly C. Chen, DO, MSHLM, discusses the potential benefits of interchangeable biosimilars to patients and payers.
Source: ajmc.com
Interchangeability In Biosimilars
Maia Kayal, MD, MS, defines interchangeability and reviews the requirements from the FDA, "switching studies," and meaningful difference verses class effect.
Source: ajmc.com
Patient and Provider Education on Biosimilars
A panel of experts review the emerging interchangeable biosimilars and best practices on how to educate providers and patients on interchangeable biosimilars.
Source: ajmc.com
Existing FDA-Approved Biosimilars
Jonathan Kay, MD, provides an overview of the existing FDA-approved biosimilars for adalimumab.
Source: ajmc.com